Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musa

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Annals of Tropical Medicine and Parasitology|January 12, 2008
Revival of a focus of visceral leishmaniasis in central SudanE A G Khalil, A M Musa, S H H Elgawi, et al.
Journal of Family Medicine and Primary Care|June 15, 2019
Serum vitamin D level, sun-exposed area, dietary factors, and physical activity as predictors of invasive breast cancer risk among Sudanese women: A case-control studyNazik Elmalaika Husain, Ahmed A Suliman, Ismail Abdelrahman, et al.
Trials|July 2, 2011
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trialRaymond Omollo, Neal Alexander, Tansy Edwards, et al.
The Journal of Antimicrobial Chemotherapy|September 19, 2023
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasisLuka Verrest, Ignace C Roseboom, Monique Wasunna, et al.
Plos Neglected Tropical Diseases|April 19, 2024
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic modelLuka Verrest, Séverine Monnerat, Ahmed M Musa, et al.
Current HIV/AIDS Reports|June 4, 2021
Strategies for Successful Clinical Trial Recruitment of People Living with HIV in Low- and Middle-Income Countries: Lessons Learned and Implementation Implications from the Nigeria Renal Risk Reduction (R3) TrialAima A Ahonkhai, Usman J Wudil, Faisal S Dankishiya, et al.
Scientific Reports|December 10, 2025
Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in AfricaI A Aliyu, J A Bala, B M Musa, et al.
Journal of Tropical Medicine|May 22, 2013
Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the SudanA M Musa, E A G Khalil, B M Younis, et al.
The Medical Journal of Malaysia|December 2, 2025
Factors associated with hypertension among the elderly in Kudat, MalaysiaW H N M Lotfi, N Azhar, A Alias, et al.
Annals of Clinical and Laboratory Science|May 9, 2025
Adrenal Insufficiency among People Living with HIV in Africa: Does Salivary Cortisol Make a Difference?Mansur A Ramalan, Zainab U Ibrahim, Aishatu M Nalado, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Annals of Tropical Medicine and Parasitology|January 12, 2008
Revival of a focus of visceral leishmaniasis in central SudanE A G Khalil, A M Musa, S H H Elgawi, et al.
Journal of Family Medicine and Primary Care|June 15, 2019
Serum vitamin D level, sun-exposed area, dietary factors, and physical activity as predictors of invasive breast cancer risk among Sudanese women: A case-control studyNazik Elmalaika Husain, Ahmed A Suliman, Ismail Abdelrahman, et al.
Trials|July 2, 2011
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trialRaymond Omollo, Neal Alexander, Tansy Edwards, et al.
The Journal of Antimicrobial Chemotherapy|September 19, 2023
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasisLuka Verrest, Ignace C Roseboom, Monique Wasunna, et al.
Plos Neglected Tropical Diseases|April 19, 2024
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic modelLuka Verrest, Séverine Monnerat, Ahmed M Musa, et al.
Current HIV/AIDS Reports|June 4, 2021
Strategies for Successful Clinical Trial Recruitment of People Living with HIV in Low- and Middle-Income Countries: Lessons Learned and Implementation Implications from the Nigeria Renal Risk Reduction (R3) TrialAima A Ahonkhai, Usman J Wudil, Faisal S Dankishiya, et al.
Scientific Reports|December 10, 2025
Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in AfricaI A Aliyu, J A Bala, B M Musa, et al.
Journal of Tropical Medicine|May 22, 2013
Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the SudanA M Musa, E A G Khalil, B M Younis, et al.
The Medical Journal of Malaysia|December 2, 2025
Factors associated with hypertension among the elderly in Kudat, MalaysiaW H N M Lotfi, N Azhar, A Alias, et al.
Annals of Clinical and Laboratory Science|May 9, 2025
Adrenal Insufficiency among People Living with HIV in Africa: Does Salivary Cortisol Make a Difference?Mansur A Ramalan, Zainab U Ibrahim, Aishatu M Nalado, et al.
Pageof 26